Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention.

Engelman CD, Koscik RL, Jonaitis EM, Okonkwo OC, Hermann BP, La Rue A, Sager MA.

J Alzheimers Dis. 2013;36(4):749-57. doi: 10.3233/JAD-130482.

2.

ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan.

Liao YC, Lee WJ, Hwang JP, Wang YF, Tsai CF, Wang PN, Wang SJ, Fuh JL.

Neurobiol Aging. 2014 Oct;35(10):2423.e7-2423.e13. doi: 10.1016/j.neurobiolaging.2014.05.009. Epub 2014 May 14.

PMID:
24908168
3.

Aging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention.

Jonaitis EM, Koscik RL, La Rue A, Johnson SC, Hermann BP, Sager MA.

Clin Neuropsychol. 2015;29(4):426-41. doi: 10.1080/13854046.2015.1047407. Epub 2015 May 27.

4.

ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.

Macé S, Cousin E, Ricard S, Génin E, Spanakis E, Lafargue-Soubigou C, Génin B, Fournel R, Roche S, Haussy G, Massey F, Soubigou S, Bréfort G, Benoit P, Brice A, Campion D, Hollis M, Pradier L, Benavides J, Deleuze JF.

Neurobiol Dis. 2005 Feb;18(1):119-25.

PMID:
15649702
5.

Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.

Jiang S, Yang W, Qiu Y, Chen HZ; Alzheimer's Disease Neuroimaging Initiative (ADNI)..

Curr Alzheimer Res. 2015;12(3):218-27.

PMID:
25731621
6.

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M, Nguyen T, Malphrus KG, Ma L, Bisceglio GD, Roberts RO, Lucas JA, Smith GE, Ivnik RJ, Machulda MM, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2015 Jan;36(1):60-7. doi: 10.1016/j.neurobiolaging.2014.07.042. Epub 2014 Aug 4.

7.

Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.

Cuyvers E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, Bettens K, Vermeulen S, Mattheijssens M, Peeters K, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K.

Lancet Neurol. 2015 Aug;14(8):814-22. doi: 10.1016/S1474-4422(15)00133-7. Epub 2015 Jun 30.

PMID:
26141617
8.

Association study of cholesterol-related genes in Alzheimer's disease.

Wollmer MA, Sleegers K, Ingelsson M, Zekanowski C, Brouwers N, Maruszak A, Brunner F, Huynh KD, Kilander L, Brundin RM, Hedlund M, Giedraitis V, Glaser A, Engelborghs S, De Deyn PP, Kapaki E, Tsolaki M, Daniilidou M, Molyva D, Paraskevas GP, Thal DR, Barcikowska M, Kuznicki J, Lannfelt L, Van Broeckhoven C, Nitsch RM, Hock C, Papassotiropoulos A.

Neurogenetics. 2007 Aug;8(3):179-88. Epub 2007 Mar 27.

PMID:
17387528
9.

Association of genetic variants of ABCA1 with Alzheimer's disease risk.

Rodríguez-Rodríguez E, Mateo I, Llorca J, Sánchez-Quintana C, Infante J, García-Gorostiaga I, Sánchez-Juan P, Berciano J, Combarros O.

Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):964-8.

PMID:
17510946
10.

APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.

Klages JD, Fisk JD, Rockwood K.

Dement Geriatr Cogn Disord. 2003;15(1):1-5.

PMID:
12457072
11.

An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.

Lescai F, Chiamenti AM, Codemo A, Pirazzini C, D'Agostino G, Ruaro C, Ghidoni R, Benussi L, Galimberti D, Esposito F, Marchegiani F, Cardelli M, Olivieri F, Nacmias B, Sorbi S, Tagliavini F, Albani D, Martinelli Boneschi F, Binetti G, Santoro A, Forloni G, Scarpini E, Crepaldi G, Gabelli C, Franceschi C.

J Alzheimers Dis. 2011;24(2):235-45. doi: 10.3233/JAD-2011-101764.

PMID:
21263195
12.

Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.

Chen DW, Yang JF, Tang Z, Dong XM, Feng XL, Yu S, Chan P.

Brain Res. 2008 Jan 2;1187:52-7. Epub 2007 Nov 26.

PMID:
18036514
13.

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.

Psychol Med. 2009 Nov;39(11):1907-11. doi: 10.1017/S0033291709005492. Epub 2009 Apr 1.

PMID:
19335933
14.

Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.

Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM.

PLoS One. 2012;7(11):e50976. doi: 10.1371/journal.pone.0050976. Epub 2012 Nov 30.

15.

The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.

Polito L, Kehoe PG, Davin A, Benussi L, Ghidoni R, Binetti G, Quadri P, Lucca U, Tettamanti M, Clerici F, Bagnoli S, Galimberti D, Nacmias B, Sorbi S, Guaita A, Scarpini E, Mariani C, Forloni G, Albani D.

Alzheimers Dement. 2013 Jul;9(4):392-9. doi: 10.1016/j.jalz.2012.02.003. Epub 2012 May 30.

PMID:
22651940
16.

Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.

Bracco L, Piccini C, Baccini M, Bessi V, Biancucci F, Nacmias B, Bagnoli S, Sorbi S.

Dement Geriatr Cogn Disord. 2007;24(6):483-91. Epub 2007 Nov 15.

PMID:
18025782
17.

Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.

Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco M, Dominici R, Albertini A, Finazzi D.

Neurobiol Aging. 2008 Oct;29(10):1494-501. Epub 2007 Apr 26.

PMID:
17466415
18.

Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk.

Rodríguez-Rodríguez E, Mateo I, Infante J, Llorca J, García-Gorostiaga I, Vázquez-Higuera JL, Sánchez-Juan P, Berciano J, Combarros O.

Brain Res. 2009 Jul 14;1280:166-71. doi: 10.1016/j.brainres.2009.05.019. Epub 2009 May 14.

PMID:
19446537
19.

A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.

Keenan BT, Shulman JM, Chibnik LB, Raj T, Tran D, Sabuncu MR; Alzheimer's Disease Neuroimaging Initiative., Allen AN, Corneveaux JJ, Hardy JA, Huentelman MJ, Lemere CA, Myers AJ, Nicholson-Weller A, Reiman EM, Evans DA, Bennett DA, De Jager PL.

Hum Mol Genet. 2012 May 15;21(10):2377-88. doi: 10.1093/hmg/dds054. Epub 2012 Feb 17.

20.

Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease.

Sundar PD, Feingold E, Minster RL, DeKosky ST, Kamboh MI.

Neurobiol Aging. 2007 Jun;28(6):856-62. Epub 2006 May 24.

PMID:
16725228

Supplemental Content

Support Center